[Tough glucose reduction necessary in newly diagnosed diabetes].
作者信息
Rydén Mikael
机构信息
Kliniken för endokrinologi, metabolism och diabetes, Karolinska universitets-sjukhuset, Huddinge.
出版信息
Lakartidningen. 2010;107(45):2810-4.
PMID:21179867
Abstract
摘要
相似文献
1
[Tough glucose reduction necessary in newly diagnosed diabetes].[新诊断糖尿病患者需严格控制血糖]
Lakartidningen. 2010;107(45):2810-4.
2
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?药物治疗对2型糖尿病微血管和大血管并发症的影响：证据水平如何？
Diabetes Metab. 2014 Jun;40(3):169-75. doi: 10.1016/j.diabet.2013.12.010. Epub 2014 Feb 3.
3
Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.肠促胰岛素增强剂与2型糖尿病降糖治疗的演变
Endocrinol Metab Clin North Am. 2007 Dec;36 Suppl 2 Incretin:2-17.
4
A summary of the ADVANCE Trial.ADVANCE试验总结。
Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S357-61. doi: 10.2337/dc09-S339.
5
UKPDS and the legacy effect.英国前瞻性糖尿病研究（UKPDS）及其遗留效应。
N Engl J Med. 2008 Oct 9;359(15):1618-20. doi: 10.1056/NEJMe0807625.
6
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
7
Glycemic durability of monotherapy for diabetes.糖尿病单药治疗的血糖耐久性
N Engl J Med. 2007 Mar 29;356(13):1378-9; author reply 1380. doi: 10.1056/NEJMc063760.
8
Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.2型糖尿病二线治疗起始后糖化血红蛋白水平的变化：一项初级保健数据库研究
Diabetes Obes Metab. 2016 Aug;18(8):840-3. doi: 10.1111/dom.12673. Epub 2016 May 16.
9
Treatment of Pediatric Type 2 Diabetes.儿童2型糖尿病的治疗
Ann Pharmacother. 2016 Sep;50(9):768-77. doi: 10.1177/1060028016655179. Epub 2016 Jun 15.
10
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?胰岛素作为2型糖尿病的一线治疗：是否应停止使用磺脲类药物？
Diabetes Care. 2008 Feb;31 Suppl 2:S136-9. doi: 10.2337/dc08-s234.
Zotero 插件